Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-033622
Filing Date
2019-05-31
Accepted
2019-05-31 16:07:40
Documents
1
Period of Report
2019-05-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 10525
  Complete submission text file 0001209191-19-033622.txt   11860
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS INC (Issuer) CIK: 0001439222 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AGIOS PHARMACEUTICALS, INC. 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Ho Maykin (Reporting) CIK: 0001646395 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36014 | Film No.: 19870499